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Abstract
Background: There is growing concern about development of antimicrobial resistance due to use of antimicrobials
(AMs) in livestock production. Identifying efficient alternatives, including vaccination, is a priority. The objective of
this study was to compare the herd-level amount of AMs prescribed for weaner pigs, between Danish sow herds
using varying combinations of vaccines against Porcine Circovirus Type 2 (PCV2), Mycoplasma hyopneumoniae
(MYC) and Lawsonia intracellularis (LAW). It was hypothesised that herds purchasing vaccines, use these to prevent
disease, and hence reduce their AM consumption, compared to herds purchasing fewer or no vaccines against
these pathogens.
Data summarised over year 2013 were obtained from the Danish Central Husbandry Register and the Danish
VetStat database, in which prescriptions of medication are recorded. All one-site indoor pig herds with >50 sows
and >200 weaners were selected. AMs prescribed for weaners was measured in animal daily doses (ADD) and
divided according to three indication groups (gastro-intestinal, respiratory indication or total use). The analysis was
based on three multivariable linear regression models of the herd-level ADD for each indication group. The eight
vaccination combinations (2x2x2) were included as one explanatory variable, and herd size, measured as the
number of weaner pen places was included in the models as a potential confounder.
Results: Out of the 1513 herds in the study, 1415 had AMs prescribed for gastro-intestinal disorders, and 836 for
respiratory disorders. PCV2 vaccines were purchased in 880 herds, MYC vaccines in 787 and LAW vaccines in 115
herds. Herds purchasing PCV2 and MYC vaccines had significantly more AMs prescribed than herds not purchasing
vaccines or only purchasing LAW vaccines.
Conclusion: In the present study, using register data covering 1 year, we found an association between use of
vaccination and increased amount of AMs prescribed for weaners. This does not exclude that the vaccines work,
just that we were unable to detect this. The findings might be explained by some herds experiencing clinical
problems associated with MYC or PCV2 despite use of vaccination. In other herds, it might reflect that vaccines
applied to weaners are used for disease prevention in finishers rather than in the weaners. Information about
vaccination protocols and herd health status was not available at the time of the study. Hence, further studies are
required to investigate causality of the associations between use of AMs, vaccination practices and other
confounding on-farm factors.
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Background
In Denmark, there has been political and public focus
on the use of antimicrobials (AMs) in livestock and the
risk of development of AM resistance since the 1990s.
Focus is in particularly on the Danish pig industry,
because it is the largest livestock industry in Denmark;
around 28 million pigs are produced annually, and
around 10 million of these are exported as weaners [1].
As a result, a series of events emerged in and around the
pig industry: (a) in 1995, the veterinary profit from sales
of AMs was officially limited to 5-10 % [2]; (b) in 1998,
an industry initiative leading to the phasing out of
growth promoters was introduced for finishing pigs, and
this was expanded to weaners in 1999 (effective from
January 1, 2000) [3] (c) increased surveillance and
regulation of veterinary practice and prescriptions was
undertaken [4], as well as (d) recommendations and
guidelines for prudent use of AMs were developed. More-
over, in 2010, an industry-driven ban was implemented to
stop the use of cephalosporins in pigs produced in
Denmark [1].
To support the Danish policy, data regarding medical
consumption for production animals are collected in a
national database called VetStat established mid-2000
[5]. VetStat collects prescription records from pharma-
cies, feed mills and veterinary practitioners [5]. A pre-
scription record includes information about the type,
concentration and amount of AMs, the treatment indi-
cation, the age group, the individual herd number, the
date of issue, the name of the veterinarian prescribing,
and the name of the producer [5].
Between 2008 and the first half of 2010, the AM con-
sumption in pigs increased, leading to a public debate
[1]. Consequently, in 2010 the Danish veterinary author-
ities adopted the “Yellow Card” initiative, a scheme that
sets permit limits to AM use in swine herds [1]. Until
June 2013, the Yellow Card permit limit for weaners was
28 ADD per 100 weaners per day. Thereafter, the permit
limit was reduced to 25 ADD per 100 animal days [1]
and www.foedevarestyrelsen.dk. By November 2014, the
permit limits were further reduced to 22.9 ADD per 100
weaners per day (Please see www.foedevarestyrelsen.dk
for further updates).
The introduction of the Yellow Card scheme reflected
the political pressure that is forcing Danish pig
producers to reduce the usage of AMs on their farms.
Therefore, efficient alternatives to routinely applied AMs
have become crucial.
Vaccines are being considered a potential tool to
decrease the burden of animal diseases and also to re-
duce the need for AMs with therapeutic purposes [6, 7].
According to data from VetStat, the three most
commonly used vaccines in Danish pig production is
against Mycoplasma hyopneumoniae (MYC) (36 %),
Porcine Circovirus Type 2 (PCV2) (26 %), and Actinoba-
cillus pleuropneumoniae (APP) (8 %), whereas only 3 %
of the vaccine doses were prescribed for Lawsonia intra-
cellularis (LAW) and only 2 % for Porcine Reproductive
and Respiratory Syndrome (PRRS). These endemic dis-
ease agents are representing common production-related
diseases in weaners and finishers in modern pig produc-
tion. We decided to focus on the effect of MYC, PCV2
and LAW. We included MYC and PCV2 because they are
the most commonly used vaccines, and we included LAW
to have a vaccine with an effect on gastro-intestinal
lesions. We excluded PRRS for two reasons: 1) low use
and 2) apparently, in Denmark PRRS vaccines are used
more commonly in breeding animals than in weaners.
PCV2 has a causal role in a large number of clinical
syndromes, which are collectively named as Porcine
Circovirus Diseases (PCVDs) and is highly prevalent
worldwide [8]. The most economically significant
condition within PCVDs is post-weaning multi-systemic
wasting syndrome (PMWS) [8]. However, PCV2 can also
play a role in the occurrence of reproductive failure,
enteritis, porcine dermatitis and nephropathy syndrome
and proliferative necrotizing pneumonia [9]. Further-
more, when there is an interaction between bacterial
and viral agents, the syndrome is called porcine respira-
tory disease complex (PRDC) [10].
MYC is the primary agent responsible for swine enzo-
otic pneumonia, which is a chronic respiratory disease
that causes significant economic losses worldwide and is
highly prevalent in most areas of pig production (present
in between 38 to 100 % of the pig farms world-wide) [9].
MYC predisposes the infected animals to secondary
infections, which can increase the severity of the disease
for example seen as PRDC [9].
LAW is the causative bacterium of proliferative enter-
opathy, and it is a common high prevalence intestinal
infection worldwide including Denmark [11]. This has a
direct impact on pig production and herd economics
as it affects growing pig performance due to the
decrease in growth rates and feed conversion in some
herds [12, 13].
PCV2, MYC and LAW can be controlled and
prevented by different interventions. In Denmark, these
include all in/all out production, multisite production,
increased hygiene, antibiotic medication and use of
vaccination. In Denmark, these vaccines have been used
as an alternative to antibiotic medication and to increase
productivity in weaners and finishers. The use of these
vaccines has increased substantially since 2010. This was
observed in particular right after the introduction of the
Yellow Card, e.g. the use of vaccines against PCV2 infec-
tions increased by 31 % [1].
To explore the potential of using vaccination as an
alternative to AMs, the present study was carried out
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using data from VetStat and the Danish Central Hus-
bandry Register (CHR) from all one-site pig herds with
>50 sows and >200 weaners in the year 2013. The
objective was to compare the total amount of AMs
prescribed for weaning pigs between Danish sow herds
using varying combinations of vaccines against PCV2,
MYC and LAW that year. It was assumed that year 2013
represented a steady-state in the use of vaccines and
AMs. Hence, bias caused by confounding factors related
to dynamics in overall health and production conditions
including changes in legislation and market forces could
be avoided. It was also assumed that the AMs and
vaccines prescribed were used in the herd.
Results
Basic statistics
The median number of sows in the 1513 herds was 435
and the maximum was 3100 sows. For weaners, the
median number of pen places was 1500 whereas the
maximum was 21,000. Around half (52 %) of the herds
also had production of finishing pigs on the same
premises.
Out of the 1513 herds selected for the study, 1415 herds
had AMs prescribed for gastrointestinal disorders in
weaners, and 836 herds had AMs prescribed for respiratory
disorders, corresponding to 94 and 55 % of the herds,
respectively. There were no herds with no AMs prescribed.
With respect to total AM consumption (AC-TOTAL),
the median use was 10.0 ADD per 100 weaners per day
(Min: 0.004; Max: 79.33). The herd-level distribution of
the total AM consumption was not normal but posi-
tively skewed with 58 herds corresponding to 4 % having
AM consumption above 28 ADD per 100 weaners per
day, which was the initial Yellow Card threshold.
The main part (67 %) of the AM consumption for
weaners was prescribed for gastro-intestinal disorders.
The overall median was 6.9 ADD per 100 weaners per
day (Min: 0.02; Max: 67.16). The herd-level distribution
of AM consumption with gastro-intestinal indication
(AC-GI) was not normal, but positively skewed with 20
herds having AM consumption above 28 ADD per 100
weaners per day.
The median AM consumption with respiratory indica-
tion (AC-RESP) was 2.5 ADD per 100 weaners per day
(Min: 0.01; Max: 56.20). The herd-level distribution of
AM consumption with respiratory indication was not
normal; and 17 of the herds had AM consumption above
28 ADD per 100 weaners per day.
Concerning the vaccines, 58 % (n = 880) of the herds
purchased PCV2 vaccines in 2013. MYC vaccination was
purchased in 52 % (n = 787) of the herds, and LAW
vaccination was the least used vaccine, with just 8 %
(n = 115) of the herds having at least one registered
purchase of Enterisol®Ileitis. A total of 380 herds did
not have any of these three vaccines prescribed in
2013 (Table 1).
Results of multivariable analyses
With respect to total AM consumption (Table 1), the
variable herd size and the variable representing vaccine
use were both statistically significant (P < 0.0001). Some
degree of confounding between herd size and the vac-
cine use variable was observed but only for the param-
eter describing use of PCV2 and LAW (n = 35 herds).
The interaction between herd size and vaccine use was
non-significant (P = 0.48). A model with vaccine use and
herd size only explained 7 % of the variance in the total
AM consumption (R2 = 0.07, F = 12.2, P < 0.001). The
highest use was observed in Group 4 (10.3 ADD/100
weaners/day), representing use of MYC and PCV2 vac-
cination, whereas the lowest consumption was observed
in Group 6 (6.0 ADD/100 weaners/day), representing
use of MYC and LAW vaccination. Group 1, 2, and 4,
representing three different combinations of use of MYC
and PCV2 vaccination, were all associated with a statisti-
cally higher AM consumption than the use of no vaccine
at all (group 0); between 1.8 and 3.7 higher ADD per
100 weaners per day compared with group 0. The
remaining vaccine combination groups were not associ-
ated with statistically different levels of AM consump-
tion compared to the group not using any of the three
vaccines (P > 0.05). Smaller herds had a significantly
lower total AM consumption than medium-sized herds
(6.6 versus 8.0 ADD/100 weaners/day), which again had
a significantly lower consumption than large herds
where the mean AM consumption was 9.2 ADD/100
weaners/day (Table 1).
Regarding AM consumption for gastro-intestinal indica-
tion (Table 2), only herd size was statistically significant
(P = 0.02). Some degree of confounding between herd size
and the vaccine use variable was observed but only for the
parameter related to the group using LAW vaccine alone
(n = 21 herds). The variable describing the vaccine use had
a P-value of 0.2, and the interaction term between herd
size and vaccine use had a P-value of 0.37. A model in-
cluding vaccine use and production size only explained
0.6 % of the variance in the AM consumption (R2 = 0.006,
F = 2.0, P = 0.03) (Table 2). Large herds had significantly
higher AM consumption than small herds (6.8 versus 5.7
ADD/100 weaners/day), whereas the AM consumption in
medium-sized herds were in between. A detailed look into
Table 2 shows that the lowest AM consumption was ob-
served in Group 0, 2, 3 and 6 (5.7–6.0 ADD/100 weaners/
day) and the highest use in Group 5 (7.0 ADD/100
weaners/day).
In relation to the AC with respiratory indication
(Table 3), herd size was non-significant (P = 0.06) but
some confounding between herd size and vaccine use
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Table 2 Final multivariable model* of the associations between use of vaccines and consumption of antimicrobials with gastro-intestinal
indications (AC-GI) in 1415 Danish sow herds after controlling for production size, 2013. Group 0 (no vaccination) and small herd size were
used as reference classes
Variables and classes AC-GI
(ADD/100 weaners/day)
Converted AC-GI
(ADD/100 weaners/day)
Estimate of square
root-transformed
outcome
Standard error P-value Mean
estimate
Lower 95 % CI Upper 95 % CI
Intercept 2.384 0.076 <0.0001 5.7 5.0 6.4
Combinations of vaccines 0.2
Group 0: PCV2 = 0 & MYC = 0 & LAW = 0 (n = 351) 0.000 n.a. 5.7 n.a. n.a.
Group 1: PCV2 = 1 & MYC = 0 & LAW = 0 (n = 277) 0.145 0.097 6.4 5.5 7.4
Group 2: PCV2 = 0 & MYC = 1 & LAW = 0 (n = 204) −0.004 0.106 5.7 4.7 6.7
Group 3: PCV2 = 0 & MYC = 0 & LAW = 1 (n = 21) 0.021 0.270 5.8 3.5 8.6
Group 4: PCV2 = 1 & MYC = 1 & LAW = 0 (n = 476) 0.183 0.085 6.6 5.8 7.5
Group 5: PCV2 = 1 & MYC = 0 & LAW = 1 (n = 32) 0.258 0.222 7.0 4.9 9.5
Group 6: PCV2 = 0 & MYC = 1 & LAW = 1 (n = 9) 0.058 0.405 6.0 2.7 10.5
Group 7: PCV2 = 1 & MYC = 1 & LAW = 1 (n = 45) −0.026 0.190 5.6 3.9 7.5
Herd size (number of weaners pen places) 0.02
Small (n = 468)a 0.000 n.a. 5.7 n.a. n.a.
Medium (n = 585)a,b 0.151 0.075 6.4 5.7 7.2
Large (n = 362)b 0.227 0.085 6.8 6.0 7.7
n.a. not applicable, PCV2 Porcine Circovirus Type 2, MYC Mycoplasma hyopneumoniae, LAW Lawsonia intracellularis
a, b – different letters indicate variable classes with significantly different parameter estimates of antimicrobial consumption according to an F-test
*Model statistics: R2 = 0.006, F = 2.0, P = 0.03
Table 1 Final multivariable model* of the associations between the use of vaccines and total consumption of antimicrobials (AC-TOTAL)
measured as Animal Daily Doses (ADD) per 100 weaners per day in 1513 Danish sow herds after controlling for production size, 2013.
Group 0 (no vaccination) and small herd size were used as reference classes
Variables and classes AC-TOTAL
(ADD/100 weaners/day)
Converted AC-TOTAL
(ADD/100 weaners/day)
Estimate of square
root-transformed
outcome
Standard error P-value Mean
estimate
Lower 95 % CI Upper 95 % CI
Intercept 2.573 0.0732 <0.0001 6.6 5.9 7.4
Combinations of vaccines <0.0001
Group 0: PCV2 = 0 & MYC = 0 & LAW = 0 (n = 380)a 0.000 n.a. 6.6 n.a. n.a.
Group 1: PCV2 = 1 & MYC = 0 & LAW = 0 (n = 290)b,d 0.324 0.096 8.4 7.3 9.5
Group 2: PCV2 = 0 & MYC = 1 & LAW = 0 (n = 221)b,c,d 0.433 0.103 9.0 7.9 10.3
Group 3: PCV2 = 0 & MYC = 0 & LAW = 1 (n = 21)a,b,c,d 0.192 0.274 7.6 5.0 10.9
Group 4: PCV2 = 1 & MYC = 1 & LAW = 0 (n = 507)c,d 0.635 0.084 10.3 9.3 11.4
Group 5: PCV2 = 1 & MYC = 0 & LAW = 1 n = 35)a,d 0.083 0.216 7.1 5.0 9.5
Group 6: PCV2 = 0 & MYC = 1 & LAW = 1 (n = 11)a,b,c,d −0.118 0.374 6.0 3.0 10.2
Group 7: PCV2 = 1 & MYC = 1 & LAW = 1 (n = 48)a,b,c,d 0.202 0.188 7.7 5.8 9.9
Herd size (number of weaner pen places) <0.0001
Small (n = 528)a 0.000 n.a. 6.6 n.a. n.a.
Medium (n = 607)b 0.264 0.073 8.0 7.3 8.9
Large (n = 378)c 0.459 0.083 9.2 8.2 10.2
n.a. not applicable, PCV2 Porcine Circovirus Type 2, MYC Mycoplasma hyopneumoniae, LAW Lawsonia intracellularis
a, b, c, d – different letters indicate variable classes with significantly different parameter estimates of antimicrobial consumption according to an F-test
*Model statistics: R2 = 0.07, F = 12.2, P < 0.001
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was observed for two of the parameter estimates of the
vaccine variable (use of LAW vaccine alone: 10 herds; use
of MYC and LAW vaccines: 6 herds). The interaction
term between herd size and vaccine use was non-
significant (P = 0.80), whereas the variable describing
vaccine use was statistical significant (P < 0.0001), but it
only explained 4 % of the variance in the AM consump-
tion (R2 = 0.04, F = 4.8, P = 0.001). The lowest AM
consumption was observed in Group 5, representing the
use of PCV2 and LAW vaccination (0.6 ADD/100
weaners/day). However, this was not significantly different
from Group 0, statistically speaking (1.6 ADD/100
weaners/day). Group 2 and 4 representing use of MYC
vaccination with and without concurrent use of PCV2
vaccination were associated with a statistically higher AM
consumption than the use of no vaccines (Group 0) – 3.1
and 3.2 versus 1.6 ADD/100 weaners/day. The changes in
AM consumption associated with the rest of the combina-
tions were not statistically significant (P > 0.05).
Discussion
General discussion
Almost all herds (96 %) had a total AM consumption
lower than 28 ADD per 100 weaners per day This implies
that the majority of the producers were able to raise
weaners while fulfilling the requirements regarding AM
consumption set by the Danish veterinary authorities.
The statistical analyses showed that in general the pig
herds using vaccines against MYC, PCV2 and LAW had
a higher – and not as hypothesised a lower AM con-
sumption – in the weaning stage compared to not using
vaccination at all. This is in line with results presented by
Potsma et al. (2016) [14]. This may be explained by some
herds experiencing clinical problems associated in particu-
lar with MYC or PCV2 despite use of vaccination. The
herds not applying vaccination are probably herds with a
high health status, where these three infections are not
present – or at least not causing clinical problems. In
other herds, the lack of impact of vaccination on the AM
consumption in weaners might reflect that vaccines are
used for disease prevention in finishers rather than in the
weaners as pointed out by Raidt et al. [15]. Alternatively,
other infections may be present which we could not adjust
for in the statistical analyses. Moreover, in Denmark much
has already been done to lower the antimicrobial con-
sumption; latest with the Yellow Card scheme setting limi-
tations to the consumption in an age group such as the
weaners as described above. Finally, the lack of effect of the
vaccine combinations on the AM with gastro-intestinal
indication may be explained by the fact that only the LAW
vaccine has a direct impact on gastro-intestinal infections.
Effect of PCV2 vaccination
Control of PCV2-related diseases has traditionally been
based on preventive measures such as: (1) improved
Table 3 Final multivariable model* of the associations between use of vaccines and consumption of antimicrobials with respiratory
indications (AC-RESP) in 836 Danish sow herds after controlling for production size, 2013. Group 0 (no vaccination) and small herd
size were used as reference classes
Variables and classes AC-RESP
(ADD/100 weaners/day)
Converted AC-RESP
(ADD/100 weaners/day)
Estimate of
log-transformed
outcome
Standard error P-value Mean
estimate
Lower 95 % CI Upper 95 % CI
Intercept 0.497 0.145 <0.0001 1.6 1.2 2.2
Combinations of vaccines <0.0001
Group 0: PCV2 = 0 & MYC = 0 & LAW = 0 (n = 155)a,c 0.000 n.a. 1.6 n.a. n.a.
Group 1: PCV2 = 1 & MYC = 0 & LAW = 0 (n = 136)a 0.404 0.177 2.5 1.7 3.5
Group 2: PCV2 = 0 & MYC = 1 & LAW = 0 (n = 134)b 0.648 0.177 3.1 2.2 4.4
Group 3: PCV2 = 0 & MYC = 0 & LAW = 1 (n = 10)a,c 0.160 0.490 1.9 0.7 5.0
Group 4: PCV2 = 1 & MYC = 1 & LAW = 0 (n = 349)b 0.672 0.146 3.2 2.4 4.3
Group 5: PCV2 = 1 & MYC = 0 & LAW = 1 (n = 13)c −0.994 0.434 0.6 0.3 1.4
Group 6: PCV2 = 0 & MYC = 1 & LAW = 1 (n = 6)a,b,c −0.166 0.626 1.4 0.4 4.7
Group 7: PCV2 = 1 & MYC = 1 & LAW = 1 (n = 33)a,b,c 0.220 0.289 2.0 1.2 3.6
Herd size (number of weaners pen places) 0.06
Small (n = 235) 0.000 n.a. 1.6 n.a. n.a.
Medium (n = 331) −0.261 0.129 1.3 1.0 1.6
Large (n = 270) −0.295 0.136 1.2 0.9 1.6
n.a. not applicable, PCV2 Porcine Circovirus Type 2, MYC Mycoplasma hyopneumoniae, LAW Lawsonia intracellularis
a, b, c – different letters indicate variable classes with significantly different parameter estimates of antimicrobial consumption according to an F-test
*Model statistics: R2 = 0.04, F = 4.8, P = 0.001
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management practices in order to control risks or trigger-
ing factors, (2) control of concurrent infections and (3)
changes of the boar genetic background [8]. Currently,
disease control is mainly based on vaccination, which has
been shown to be very effective in reducing viraemia, im-
proving production parameters (e.g. reducing mortality
and increasing average daily weight gain) and the prob-
ability of co-infection by other pathogens [16–18].
In the present study, herds using PCV2 vaccination
had a statistically significantly higher total AM consump-
tion and AM consumption with respiratory indication
compared to herds not using the vaccines – except from
the case when LAW vaccination was applied as well
(Table 1). This is contrary to results presented by Raidt et
al. [15] who followed the consumption of antimicrobials
in 65 Austrian swine herds after the first licensing of the
PCV2 in Austria. The Danish results can probably be ex-
plained by reverse causality hereby pointing to PCV2’s
presence in the herds and its ability to cause disease.
Moreover, as explained above, there may be an effect of
vaccination on the finishers as shown by [15].
As described above, PCV2 has been linked with various
clinical syndromes in different organs. This might justify
the application of a major amount of AMs [19, 20]. PCV2
can be considered a necessary but not sufficient factor to
develop clinical disease [17]. Therefore, farmers and prac-
titioners could very well have decided to routinely use
PCV2 vaccination in these herds to avoid this predispos-
ing factor and consequently, the occurrence of PCVDs.
Effect of MYC vaccination
Use of vaccination against MYC has been shown to be
associated with reduced clinical signs, fewer treatment
costs and with increased average daily weight gain [21,
22]. Vaccination is therefore considered the most
adequate measure for controlling MYC infection in
practice [23]. Vaccination is performed in piglets,
weaners and to a smaller extent in grower-finishing pigs.
Vaccination of piglets during lactation is the most
common. Vaccination of replacement gilts and sows is
also performed in some herds.
According to the results of the multivariable analysis,
on average herds using MYC vaccination had a higher
total AM consumption and AM consumption with
respiratory indication than herds not using the vaccines.
This finding may be explained by reverse causality: herds
using the vaccines were likely infected with this patho-
gen – some with clinical problems. Subsequently, these
herds were using AMs with respiratory indication to
control MYC and, simultaneously using the vaccines to
avoid the predisposition of the infected animals to sec-
ondary invaders, especially other pulmonary pathogens
[9]. Other herds neither vaccinated nor treated, presum-
ably because they were not infected with MYC.
Effect of LAW vaccination
In 2013, only one vaccine was available in Denmark
against proliferative enteropathy caused by LAW. It is
used for piglets in the last part of lactation or (more
commonly) in the first week post weaning. The positive
effect of the LAW vaccine has been shown by Bak &
Rathkjen, who undertook a study in a Danish Specific
Pathogen Free herd [12]. Here, proliferative enteropathy
was prevented by use of the vaccination and improved
growth rate and a reduction in the use of AMs was ob-
served after initiation of vaccination. However, the posi-
tive effect may be more limited in non-SPF herds due to
presence of other infections. But Thaker & Bilkei (2006)
also concluded that vaccination reduced LAW-
associated losses as well as improved health and the im-
mune state of pigs in highly infected herd [24].
As LAW vaccination is used to prevent proliferative
enteropathy [12], it would be expected that herds using
the vaccination would have been associated with a lower
AM consumption with gastrointestinal indication – or
lower total AM consumption. However, there was no
statistically significant effect of the vaccine on AM con-
sumption in the weaner section (neither the total AM
consumption, nor the consumption with a gastro-
intestinal indication or respiratory indication). There
were some indications that use of LAW vaccination was
associated with a lower AM consumption with respira-
tory indication – but the findings were not statistical sig-
nificant (Table 3). This may be because LAW vaccine
has no effect on respiratory disease. However, to some
extent AMs are being used for other disease categories
than those officially prescribed for. Certain AMs, as for
example some doxycyclines, are not officially registered
for treating infections with gastro-intestinal indication in
Denmark, although they are known to be effective in
everyday practice. This may result in recordings indicating
that these AM were used for respiratory indication
although the aim was to treat gastro-intestinal infections.
Considerations, limitations and further work for the study
We assumed that the AM and vaccines prescribed in a
herd were also used in the same herd. For some countries
there may be a difference between prescription and use.
However, for Denmark it is the general belief that VetStat
data (consisting of prescription data) approximate AM use
closely over a longer period of time. One reason is that it
is the only legal way to get AM for livestock in Denmark.
This was underpinned by a recent report from the Danish
veterinary authorities stating that there are no indications
of a systematic illegal import of AMs [25].
On average, 36 % of the total amount of AMs used for
the production of a pig until slaughter is used during the
weaning period [26] although weaners only cover the
production from 7 to 30 kg, which corresponds to around
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4 weeks. This reflects that the treatment incidence is
much higher in weaners compared with finishers and sows
[24]. This is one of the reasons why the present study fo-
cused on the AM consumption for weaners. However, it
would also be of interest to study the effect of vaccination
in the sow herd on the consumption of AM in the finish-
ing section. On the other hand, according to Potsma et al.
[14] a higher AM consumption in sows tended to be asso-
ciated with higher AM consumption from birth until
slaughter, and that it was positively associated with the
number of pathogens vaccinated against.
The multivariable models presented in Tables 1, 2 and
3 only explained a limited amount of the variation in the
data. This shows that many other factors – apart from
vaccination – determine the need for AM in a given pig
herd. Information about such factors was not available
at the time of the study e.g. regarding (1) vaccination
protocols applied including age of pigs at time of vaccin-
ation (2) initiation and duration of vaccination (3) use of
other vaccines that were part of the general vaccination
program (4) herd health status including presence of
other infections, (5) internal and external biosecurity (6)
management practices (7) turnover of animals in each
herd (8) export of live animals (where vaccination
may be required by the customer). If this information
had been available, we would probably have been
capable of explaining a larger degree of the variation
in the data.
In this study, we focused on MYC, PCV2 and LAW.
One reason for only including these three vaccines in
the analysis was to avoid that the number of herds
representing different combinations of vaccine use
would become very low, because this would result in
unstable parameter estimates. We did not take into
account PRRS vaccination. Although this vaccine only
represents 2 % of the vaccines prescribed for pigs in
Denmark, it could have been a confounder in the ana-
lyses, and it would therefore be of interest to include this
in a subsequent analysis. Similarly, it would have been of
interest to include also vaccines with an effect on APP.
However, this was not done in this analysis due to the
limited use (8 % of the prescribed vaccine doses
prescribed to Danish swine). It is also possible that vac-
cination of breeding animals for E. coli to prevent E. coli
associated neonatal diarrhea in piglets, could result in
higher piglet health at weaning and therefore also affect
the medical consumption post weaning. But the contrary
is also possible; that herds applying the vaccine do this
because they have clinical problems with neonatal diar-
rhea infections requiring antimicrobial treatment despite
the use of vaccination.
This study was a first basic approach to using register
data and a cross-sectional design to describe the possible
association between vaccinations and AM use in pig
herds in Denmark. The vaccine data from VetStat have
to the authors’ knowledge not been used in analysis of
AM use before. It is not possible to elucidate the direc-
tions of these associations. A longitudinal study will
enable a better understanding of cause and effect and be
able to take into account other factors than just
vaccination.
More information is needed to assess to which extent
vaccinations – and other preventive measures - can in
fact reduce the need for the use of AMs. The feasibility
of using vaccination as a an alternative to AMs will
depend on proper disease diagnostics, the costs of vac-
cines compared to AM, effectiveness and ease of use [6].
If in the future we get an affirmative answer to this
question and farmers can see return on their investment,
improvement of pig health and productivity will occur
through a wider application of routine vaccination
instead of routine AM treatments.
Conclusions
In general, the sow herds applying MYC and PCV2
vaccination had more AMs prescribed for weaners com-
pared to sow herds not using the three studied vaccines –
probably as a result of existing health problems in the
herds prior to and/or during the use of vaccination. For
LAW vaccine there was a trend towards lower or equal
amount of prescribed AMs compared to herds not pur-
chasing any of the three vaccines. These results suggest
that vaccination alone does not necessarily come along
with a low use of AMs, despite being an asset in many
regards.
Each herd has its own challenges and several issues
need to be taken into account when it concerns alterna-
tives to AM consumption. Further studies need to be
carried out to take into consideration other factors
regarding prevention of disease, which are of extreme
importance, such as biosecurity and management prac-
tices within the herds.
Methods
Data
The data used in this study were obtained from two
sources. The first was the VetStat database, which con-
tains information about all prescriptions of AM vaccines
destined for livestock. VetStat quantifies the AM prescrip-
tions in food animal using the unit animal daily dose
(ADD), which is defined as the average maintenance dose
per kg live animal for the main indication of an AM
in a specified species [27]. This measure takes into
account the different potency of the various AM
classes. To correct for the large variation in the
weight of weaners, the official standard estimate of
15 kg was applied [27, 28].
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The second source of data was the Danish CHR regis-
ter, which contains information about location and size
of all livestock herds. All pig herds were selected for the
study, if they fulfilled the following inclusion criteria: a)
one-site indoor herds b) herds with more than 50 sows
and c) herds with more than 200 weaners. In total 1518
herds met these three criteria, and data regarding the
prescription of AMs for weaners as well as the number
of vaccine doses purchased in 2013 were obtained for
each of these herds from VetStat.
Five herds had erroneous (e.g. negative values of
recorded AM or vaccine use) or missing data records. All
cases were most likely caused by an error in VetStat. As
all the herds in the dataset were anonymised, it was not
possible to assess the reasons for these data errors. Conse-
quently, these five herds were excluded from the analysis.
For each of the remaining 1513 herds, a variable was
created to estimate the average AM consumption per 100
weaners per day. This variable was calculated using the
total administered ADD in weaners in year 2013, dividing
it by the standard weight of weaners used by VetStat
(15 kg). After this first calculation, to have the number of
ADD for each weaner, this total was divided by the num-
ber weaners (pen places) in each herd. Finally, this total
was divided by 3.65, to show the final values in ADD per
100 animals per day – which corresponds to the unit used
by VetStat to impose the official AM consumption limits.
Taking into account that weaners may receive more
than one type of vaccine, two-way combinations
between vaccination groups were constructed to assess
the possible association between different vaccinations
and AM consumption. Moreover, for the final models,
one variable with eight levels was constructed to take
into consideration all combinations of use of the three
different vaccines within the herds.
Data analyses
All data analyses were carried out in R (version 3.1.2 of
2014 – The R Foundation for Statistical Computing).
Univariable analyses were performed for the total AM
consumption (AC-TOTAL), AM consumption with
gastrointestinal indication (AC-GI) and AM consumption
with respiratory indication (AC-RESP) Figs. 1, 2 and 3).
Herd size – measured as number of weaner pen places –
was divided into three classes: small (<7500), medium
(7500–14,999), and large (≥15,000). AC-TOTAL and AC-
GI were square root transformed whereas AC-RESP was
log-transformed to normalize the distributions. Regarding
vaccination: First we went through a pre-analysis step
involving the creation of a vaccination coverage index
based on the prescriptions of vaccines in 2013. However,
it turned out not very useful, so we decided to assign
herds as vaccinated if the respective type(s) of vaccine(s)
had been prescribed during 2013 irrespective of the num-
ber of doses prescribed.
Initially, a t-test was conducted for each of the three
types of vaccination comparing the AM consumption
for herds which used the vaccine with herds which did
not use the vaccine.
For each of the two-way combinations, a t-test and a
one-way ANOVA were conducted. Following the one-
way ANOVA, a post hoc comparison – using the
TUKEY HSD test – was performed to assess the
Fig. 1 Total use of antimicrobials – measured as Animal Daily Doses (ADD) per 100 weaners per day – in 1513 Danish sow herds, divided
according to the combined use of vaccination against PCV2, Mycoplasma hyopneumoniae (MYC), and Lawsonia intracellularis (LAW), 2013
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statistical difference between the individual combina-
tions (Data not shown).
Finally, multivariable analyses were conducted for
(1) AC-TOTAL, (2) AC-GI and (3) AC-RESP as
three separate outputs. The variables herd size and
use of vaccine (divided into the eight different
combinations of use of the three vaccines) repre-
sented the explanatory variables. It was tested
whether herd size was significantly associated with
the response and whether it acted as a confounder
by being associated with the vaccine use. Moreover,
a test was made for presence of interaction between
Fig. 2 Use of antimicrobials with gastro-intestinal indication – measured as Animal Daily Doses (ADD) per 100 weaners per day – in 1415 Danish
sow herds, divided according to the combined use of vaccination against PCV2, Mycoplasma hyopneumoniae (MYC), and Lawsonia intracellularis
(LAW), 2013
Fig. 3 Use of antimicrobials with respiratory indication – measured as Animal Daily Doses (ADD) per 100 weaners per day – in 836 Danish sow
herds, divided according to the combined use of vaccination against PCV2, Mycoplasma hyopneumoniae (MYC), and Lawsonia intracellularis
(LAW), 2013
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herd size and vaccine. A P-value < 0.05 was used as
threshold for statistical significance. As part of
model validation, residuals were inspected for nor-
mal distribution.
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